AEAhmed Emam

Ahmed Emam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmed Emam has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oncologic outcomes of radical cystectomy versus trimodal therapy in management of localized muscle-invasive urothelial bladder cancer: A prospective randomized clinical trial

    by Tarek Osman, Hesham Elwakil, Ahmed Hemdan, Mohamed Ismail, Ahmed Lotfy, Ahmed Emam

    Bladder cancer is the tenth most frequently diagnosed malignancy and the thirteenth leading cause of cancer-related deaths worldwide [1]. Muscle-invasive bladder cancer (MIBC) accounts for 25% of b...

  • Open Access

    Predictors of storage lower urinary tract symptoms after bipolar transurethral resection of the prostate

    by Ahmed Emam, Karim ElSaeed

    Background: Storage lower urinary tract symptoms (LUTS) are often experienced after transurethral resection of the prostate (TURP). The purpose of this study was to determine potential risk factors that could contribute to this condition. Methods: This prospective study included 120 consecutive patients undergoing bipolar TURP. Patients undergoing other procedures besides TURP, such as cystolitholapaxy, diverticulectomy, and urethrotomy were excluded, as were patients with neurological diseases or active urinary tract infection (UTI). The standard preoperative evaluation was done routinely, including the International Prostate Symptom Score (IPSS) with its storage and voiding sub-scores, urine culture, and abdominopelvic ultrasonography with an assessment of postvoiding residual urine (PVRU). Possible preoperative, intraoperative, and postoperative variables that may lead to storage LUTS following bipolar TURP were recorded and analyzed. Results: Of 120 patients included in our study, 52 (43.3%) patients experienced storage LUTS at 1 week after catheter removal following bipolar TURP. Of the tested variables, age (68.5 ± 6.0 vs 63.7 ± 5.4 years), higher preoperative irritative IPSS subscore (11.0 ± 2.3 vs 8.0 ± 2.7), smaller prostate size (55.3 ± 12.7 vs 61.0 ± 16.3 gm), gross vs fine hemostasis of prostatic fossa, shorter catheter duration (2.3 ± 0.8 vs 3.0 ± 0.9 days), and post-TURP UTI were found to be statistically significant in univariate analysis. Using backward multivariate logistic regression, after adjustment of significant factors in univariate analysis, it was shown that IPSS irritative subscore was an independent factor affecting storage LUTS post-TURP (OR = 1.525; CI 1.298–1.79, P < 0.001). Conclusions: Variable prognostic factors were related to storage LUTS following TURP; however, preoperative IPSS irritative subscore was an independent factor associated with such a condition, which should be emphasized during preoperative patient counseling.

  • Open Access

    Effect of COVID-19 infection on Semen Parameters

    by Karim ElSaeed, Ahmed Emam

    Objective: To investigate the possible effects of coronavirus disease 2019 (COVID-19) infection on semen parameters in recovering men. Patients and methods: In this prospective study, we investigated the impact of COVID-19 infection on semen parameters in a cohort of 44 reproductive-aged men who had recently recovered from COVID-19. Two sperm samples were collected from these participants at 3 and 6 months after infection and were compared with the patients’ pre-COVID-19 semen parameters. Results: The mean age of the participants was 35±5 years. The mean duration of fever was 3 days. Most of our studied patients 32 (73%) were not hospitalized, and none were admitted to an intensive care unit. Thirty-two cases (73%) had a normal baseline semen analysis. There was no statistically significant change in semen volume after 3 or 6 months or between 3 and 6 months. Meanwhile, the sperm concentration, total sperm count, progressive sperm motility, and normal morphology significantly declined after 3 and 6 months compared with baseline. These parameters partially recovered after 6 months, compared with 3 months. In contrast to patients with normal baseline semen analysis, patients with abnormal baseline semen analysis had a significant increase in semen volume, a decrease in sperm concentration, and progressive motility at 3 and 6 months. Patients who had high-grade fever had a statistically significant change in total count at 3 and 6 months and normal morphology at 3 months compared with patients with low-grade fever. Conclusion: This study demonstrated that most semen parameters were negatively impacted after COVID-19 infection. The changes were partially reversible 6 months after the infection.

  • Open Access

    Short-term outcomes of mini-sling versus transobturator tape in the surgical management of women with stress urinary incontinence. A randomized controlled trial

    by Ahmed Emam, Khaled Teama, Tarek Salem

    The objective of this prospective randomized study was to assess the efficacy and safety of mini-sling in the management of female stress urinary incontinence (SUI) as compared to transobturator tape (TOT). A total of 42 female patients with SUI were included in this study. Patients were randomized into two equal groups, underwent either the TOT or the mini-sling procedure, and were followed up for 6 months. Compared to the TOT group, the mini-sling group had a statistically significant shorter operative time, less estimated blood loss, and a lower postoperative pain score. There was no statistically significant difference between both groups as regards postoperative fever, hospital stay, or vaginal erosion. The International Continence Index questionnaire showed a statistically significant improvement within each group after surgery, with the TOT group showing a statistically significant marginal improvement compared to the mini-sling group. Urodynamic testing showed no statistically significant difference between both groups regarding the first sensation of bladder filling, functional bladder capacity, maximal bladder capacity, postvoiding residual urine, and maximal flow rate. Both mini-slings and TOT were found to be safe and effective in treating female SUI with no clinically significant difference between both procedures.

  • Comparison Between Mini-Percutaneous Nephrolithotomy and Standard Percutaneous Nephrolithotomy in Management of Large Renal Stones: A Randomized, Controlled Clinical Trial

    by Karim Omar ElSaeed, Mohammed Metwally Sadeq, Karim Meslhy Hassan, Dana Osman, Ahmed Emam, Ahmed M. Tawfeek, Tarek Osman

    Objectives: to compare between mini PNL and the standard PNL in management of renal stones (20-40 mm) regarding operative time, fluoroscopy time, blood loss, stone free rate, and postoperative complications. Subjects and methods: This prospective randomized comparative study was carried out on 93 patients divided into 2 groups: Group A included 44 patients who underwent standard PNL, whereas Group B included 49 patients who underwent mini PNL. Results: Standard PNL showed shorter operative time yet longer hospitalization, nephrostomy and catheterization time. The mean drop in hemoglobin level was significantly lower in the mini PNL group. In the first week postoperatively, stone-free rate was higher in the standard PNL group, but this was statistically insignificant. However, 4 weeks postoperatively, stone free rate was significantly higher in group A. The postoperative pain and the need for postoperative analgesia were significantly higher in standard PNL patients. Conclusions: Standard PNL achieved higher stone free rate and shorter operative time while mini PNL had the advantage of shorter hospitalization time and lower incidence of pain and postoperative complications.


  • Open Access

    Evaluation of Galdakao-modified Valdivia position in endoscopic management of malignant ureteric obstruction

    by Ahmed Emam, Mohamed Elmoazen, Mohamed Shabayek, Amr M. Zriek, Hany Hamed Gad

    Background: Malignant ureteric obstruction (MUO) due to pelvic malignancies is challenging for endourological management and carries high failure rates for retrograde cystoscopic ureteric stenting. Methods: We adopted Galdakao-modified Valdivia (GMV) position in the management of MUO in an operating room equipped with a C-arm fluoroscopy unit and an ultrasound device. We prospectively studied the added value of this approach in 50 cases who failed retrograde ureteric stenting. Results: Thirty-seven (74%) cases were done under a high level of spinal anesthesia. Mean operative time was 62 min. Antegrade ureteric stenting succeeded in 45/50 (90%) patients who failed retrograde ureteric stenting. GMV position facilitated simultaneous retrograde and antegrade management of MUO. Eight patients (16%) underwent auxiliary cystoscopic procedures to reduce the mass over the ureteric orifice (UO) guided by antegrade methylene blue or over a probing antegrade guidewire. Nephrostomy tube was inserted in the same setting in 16/50 (32%) cases. Antegrade flow of contrast to the bladder (P < 0.001) and ureteric kinks rather than tight stenosis or infiltration of UO (P = 0.014) were significantly associated with the success of antegrade ureteric stenting. No major complications were encountered. Conclusion: GMV position is an ideal choice for management of MUO as it allows simultaneous access to the lower and the upper urinary systems to accomplish ureteric stenting either in a retrograde or an antegrade fashion as well as the ability to insert a nephrostomy tube in the same setting, thus shortening the inpatient care and this should be the standard of care in cases with MUO.

  • Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer

    by Ahmed Emam, Gregory Hermann, Kristopher Attwood, Wenyan Ji, Gaybrielle James, Michael Kuettel, James L. Mohler

    Objective: To compare the oncologic outcomes of radical prostatectomy (RP) versus external beam radiotherapy (EBRT) ± androgen deprivation therapy for primary treatment of high risk localized prostate cancer (CaP).Methods: We retrospectively reviewed a prospectively‐populated database for cases who underwent primary treatment for high risk localized CaP, had more than 2 years follow‐up, and were treated since 2006. A total of 335 cases were studied of whom 291 underwent RP and 44 underwent EBRT. Clinical characteristics, biochemical progression‐free survival (BPFS), metastasis‐free survival (MFS), cancer‐specific survival (CSS) and overall survival (OS) were compared.Results: EBRT cases were older (p < .01; mean 71 years vs. 61 years) and had longer PSA doubling time (PSADT) (p = .03; median 4.8 years vs. 3.5 years) than RP. Race, pretreatment PSA and biopsy Gleason score were similar. Median follow‐up was 5.1 (range: 2.3–12.8) years for RP versus 3.3 (range: 2–12.4) years for EBRT. Three‐ and 5‐year BPFS were 42% and 36% after RP versus 86% and 75% after EBRT (p < .01). The rate of adjuvant/salvage therapy was 58% after RP versus 20% after EBRT (p < .01). Three‐ and 5‐year MFS were 80% and 77% after RP versus 91% and 91% after EBRT (p = .11). Three‐year CSS was 98% in both groups and OS was 97% after RP versus 94% after EBRT (p = .73).Conclusions: RP had higher rates of biochemical failure and adjuvant or salvage treatment versus EBRT in high risk localized CaP. MFS trended toward benefit after EBRT, but CSS and OS remained high in both groups.


  • Does The Use Of Povidone Iodine Suppository Decrease The Infective Complications Of TRUS Guided Prostate Biopsies? A Randomized Prospective Study

    by M S Abdulbaki, A Emam, M Badawy, H S Shaker

    Purpose: Trans rectal ultrasound guided prostate biopsy can lead to urinary tract infections in 3% to 11% and sepsis in 0.1% to 5% of patients. We investigated the prevalence of different organisms among rectal flora in our community, the virulence of the most prevalent one and the effect of combined standard antibiotic prophylaxis with the use of povidone iodine suppository prior to TRUS guided biopsy of the prostate in decreasing post biopsy infectious complications. Materials and Methods: Between December 2016 and September 2017, 50 men were prospectively randomized to povidone iodine rectal cleansing (50) or no cleansing (50) before transrectal ultrasound guided prostate biopsy. Rectal swab cultures, urinalaysis, urine cultures, total leukocytic count and CRP were obtained before transrectal ultrasound guided prostate biopsy. Patients received ciprofloxacin prophylaxis and attended at 1 week follow up visit. Urinalaysis, urine cultures, total leukocytic count and CRP were obtained at follow up visit and asked about fever, UTI symptoms and examined for prostatitis and epididymo-orchitis. Results: Infectious complications were observed in 5 (10%) patients, including 2 (8%) in the treatment group and 3 (12%) in the control group (p = 0.0001). No cases of sepsis were recorded. Mean increase of CRP was higher in control group (P = 0.011). 17 patients among study population had Ciprofloxacin resistant rectal organisms on rectal swab cultures (34%). Conclusion: Usage of pre TRUS-Bx intrarectal povidone iodine suppository together with standard antibiotic prophylaxis with ciprofloxacin helps decrease post procedure infectious complications and proved to decrease incidence of infection among patients having ciprofloxacin resistant rectal organisms.


  • Evaluation of the Role of Early Second Look Cystoscopy after Complete Resection of Non-Muscle Invasive Bladder Tumors

    by K A Taema, M Shabayek, A M Tawfeek, A M Emam, M M S Khafaga

    Background: most of the bladder cancers are non-muscle invasion at the time of diagnosis. Non-Muscle invasive tumors confined to the mucosa and invading the lamina propria are classified as stage Ta and T1, respectively, according to the Tumor, Node, Metastasis (TNM) classification system. Aim of the Study: to determine the efficacy of early second look cystoscopy after complete resection of non-muscle invasive urinary bladder tumors and its impact on subsequent treatment policy. Patients and Methods: this is a prospective clinical study that was done at Urology Department, Faculty of Medicine, Ain Shams University and Damanhur Oncology Centre. A total of 40 consecutive patients with newly diagnosed non-muscle invasive bladder cancer will be enrolled in this prospective study for second-look cystoscopy with TURBT in two to six weeks after initial TURBT and follow them up in one year. Results: Single tumor was found in 22 cases (55%), while multiple tumors were recognized in 18 cases (45%) with average sizes ranging from 12mm to 70mm. Low-grade transitional cell carcinoma (TCC) was found in 26 cases (65%), whereas high-grade TCC was found in 14 cases (35%). Stage PTa tumors was found in 12 cases (30%) while 28 cases (70%) have had tumors of PT1 stage. All cases underwent an early second TURBT after (2-6) weeks which has reviled the following data. The majority of cases (28 cases) representing 70% of whole study population were free with no detection of any tumors either residual or recurrence. Residual tumors were detected in six cases (15%) all of which detected in patient with large primary tumor size exceeding 50mm or patients with multiple tumors. Whole detected residual tumors were found at edges of primary tumors ranging 2-5 mm in size which were completely resected and they were of the same stage and grade as the initial tumor. Conclusion: Our findings in this study support the notion that second-look cystoscopy with or without TURBT is a prerequisite in patients with superficial bladder cancers except for patients with solitary, small low-grade pTa tumors. It is particularly highly recommended for patients with extensive and multiple tumors at the first TURBT